Mammalian expression of SpCas9 prime editor 2 with P2A-human MLH1dn (codon optimized)

Mammalian expression of stathmin-GFP

Lentiviral vector for overexpressing transcription factor ORFs with unique 24-bp barcodes. Barcodes facilitate identification of transcription factors in pooled screens.

Lentiviral plasmid from FIRE-Cas9 system to express SS18-Frb fusion protein

Luciferase validation vector; empty vector without insert to determine baseline

Release plasmid with Cas9 working cassette, hygromycin resistance, and pSG5 replicon

Combines a gCaMP-based calcium indicator and an Arch-based voltage indicator

sgRNA expressing AAV construct with a mCherry reporter driven by hSyn promoter. (replaced the GFP in pX552 from Zhang lab with mCherry)

Expression of G protein-coupled receptors for PRESTO-Tango: parallel receptorome expression and screening via transcriptional output, with transcriptional activation following arrestin translocation

Lentivirus vector expessing Cre under EF1a promoter and puromycin under PGK promoter

10xHis-SUMO (Smt3) tagged PNGaseF (E. coli based protein expression)

FKBP12 (F36V mutant) degron-tagged hHDAC4-dCas9 fused with tagBFP, expressed under EF1-alpha promoter in a piggyBac plasmid. Expresses Blasticidin resistance under PGK promoter.

His-TEV-Cas12aUltra-BPSV40_cMyc_NP_5NLS

Mammalian expression of human alpha synuclein

CRISPR gRNA mouse knockout pooled library - Drug targets, kinases, phosphatases

Ready-to-use AAV PHP.eB particles produced from AiP11390-pAAV-DLX2.0-minBG-SYFP2-WPRE3-BGHpA (Alias: CN1390) (#163505). In addition to the viral particles, you will also receive purified AiP11390-pAAV-DLX2.0-minBG-SYFP2-WPRE3-BGHpA (Alias: CN1390) plasmid DNA. AAV vector for strong and rapid SYFP2 expression in forebrain GABAergic interneurons. The enhancer core sequence has 100% sequence conservation between mouse and human. Developed especially for rapid viral labeling in human and NHP organotypic brain slice culture. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.